US2009062532A1PendingUtilityA1

Chemical Intermediate

Assignee: ASTRAZENECA ABPriority: Oct 14, 2002Filed: Nov 19, 2007Published: Mar 5, 2009
Est. expiryOct 14, 2022(expired)· nominal 20-yr term from priority
C07D 498/08
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An acid addition salt of a compound of Formula I, wherein R 2 represents C 1-6 alkyl (optionally substituted and/or terminated by one or more substituents selected from —OH, halo, cyano, nitro and aryl) or aryl, wherein each aryl and aryloxy group, unless otherwise specified, is optionally substituted.

Claims

exact text as granted — not AI-modified
1 . An acid addition salt of a compound of Formula I 
     
       
         
         
             
             
         
       
     
     wherein R 2  represents C 1-6  alkyl (optionally substituted and/or terminated by one or more substituents selected from —OH, halo, cyano, nitro and aryl) or aryl, wherein each aryl and aryloxy group, unless otherwise specified, is optionally substituted. 
   
   
       2 . A salt according to  claim 1  in which the acid component of the acid addition salt is represented by formula A 
     
       
         
         
             
             
         
       
     
     wherein R 16  represents unsubstituted C 1-4  alkyl, C 1-4  perfluoroalkyl or phenyl, which latter group is optionally substituted by one or more substituents selected from C 1-6  alkyl, halo, nitro and C 1-6  alkoxy, and R 2  is as defined above. 
   
   
       3 . A salt according to  claim 2  wherein the salt is a toluenesulfonate, benzenesulfonate, nosylate, brosylate, besylate or mesitylate salt. 
   
   
       4 . A salt according to any previous claim in which the salt is in solid form. 
   
   
       5 . A salt according to any previous claim which is [2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-ethyl]-carbamic acid tert-butyl ester 2,4,6-trimethylbenzenesulfonic acid. 
   
   
       6 . A process for the preparation of a compound of Formula II 
     
       
         
         
             
             
         
       
     
     wherein R 1  represents a structural fragment of formula Ia 
     
       
         
         
             
             
         
       
     
     in which A represents CH 2  and R 3  represents —OH or —N(H)R 7 ;
 R 4  represents H, C 1-6  alkyl or, together with R 3 , represents ═O; 
 R 5  represents phenyl or pyridyl, both of which groups are optionally substituted by one or more substituents selected from —OH, cyano, halo, nitro, C 1-6  alkyl (optionally terminated by —N(H)C(O)OR 13a ), C 1-6  alkoxy, 
 —N(R 14a )R 14b , —C(O)R 14c , —C(O)OR 14d , —C(O)N(R 14e )R 14f , —N(R 14g )C(O)R 14h , 
 —N(R 14i )C(O)N(R 14j )R 14k , —N(R 14m )S(O) 2 R 13b , —S(O) 2 R 13c  and/or 
 —OS(O) 2 R 13d ; 
 R 7  represents H, C 1-6  alkyl, -E-aryl, -E-Het 1 , —C(O)R 9a , —C(O)OR 9b , 
 —S(O) 2 R 9c , —[C(O)] p N(R 10a )R 10b  or —C(NH)NH 2 ; 
 R 9a  to R 9d  independently represent, at each occurrence when used herein, C 1-6  alkyl (optionally substituted and/or terminated by one or more substituents selected from halo, aryl and Het 2 ), aryl, Het 3 , or R 9a  and R 9d  independently represent H; 
 R 10a  and R 10b  independently represent, at each occurrence when used herein, H or C 1-6  alkyl (optionally substituted and/or terminated by one or more substituents selected from halo, aryl and Het 4 ), aryl, Het 5 , or together represent C 3-6  alkylene, optionally interrupted by an O atom; 
 E represents, at each occurrence when used herein, a direct bond or C 1-4  alkylene; 
 B represents -Z-, -Z-N(R 12 )—, —N(R 12 )-Z-, -Z-S(O) n — or -Z-O— (in which latter two groups, Z is attached to the carbon atom bearing R 3  and R 4 ); 
 Z represents a direct bond or C 1-4  alkylene; 
 R 11  and R 12  independently represent H or C 1-6  alkyl; 
 R 13a  to R 13d  independently represent C 1-6  alkyl; 
 R 14a  and R 14b  independently represent H, C 1-6  alkyl or together represent C 3-6  alkylene, resulting in a four- to seven-membered nitrogen-containing ring; 
 R 14c  to R 14m  independently represent H or C 1-6  alkyl; and 
 n represents 0, 1 or 2; 
 p represents 1 or 2; 
 Het 1  to Het 5  independently represent, at each occurrence when used herein, five- to twelve-membered heterocyclic groups containing one or more heteroatoms selected from oxygen, nitrogen and/or sulfur, which heterocyclic groups are optionally substituted by one or more substituents selected from ═O, —OH, cyano, halo, nitro, C 1-6  alkyl, C 1-6  alkoxy, aryl, aryloxy, —N(R 15a )R 15b , —C(O)R 15c , —C(O)OR 15d , —C(O)N(R 15e )R 15f , —N(R 15g )C(O)R 15h  and —N(R 15i )S(O) 2 R 15j ; 
 R 15a  R 15i  independently represent C 1-6  alkyl aryl or R 15a  to R 15i  independently represent H; 
 and R 2  represents C 1-6  alkyl (optionally substituted and/or terminated by one or more substituents selected from —OH, halo, cyano, nitro and aryl) or aryl, wherein each aryl and aryloxy group, unless otherwise specified, is optionally substituted. 
 wherein a salt of a compound of Formula I 
 
     
       
         
         
             
             
         
       
     
     in which R 2  is as previously defined is reacted with a compound of Formula III 
     
       
         
         
             
             
         
       
     
     wherein Y represents O or N(R 7 ) and R 4 , R 5 , R 7  and B are as hereinbefore defined, at a temperature in the range of 0° C. to 100° C. for example at elevated temperature (e.g. 60° C. to reflux) in the presence of a water and in the presence of a base. 
   
   
       7 . A process according to  claim 6  in which the salt has been previously isolated in solid form. 
   
   
       8 . A process according to either  claim 6  or  claim 7  for the preparation of tert-butyl 2-{7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diaza-bicyclo[3.3.1]-non-3-yl}ethylcarbamate which comprises reacting a salt of [2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-ethyl]-carbamic acid tert-butyl ester with 4-[(2S)-oxiranylmethoxy]benzonitrile at a temperature in the range of 0° C. to 100° C. in the presence of water and in the presence of a base. 
   
   
       9 . A process according to any one of  claims 6 ,  7  or  8  in which an isolated salt of [2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-ethyl]-carbamic acid tert-butyl ester is used. 
   
   
       10 . A process according to either  claim 9  wherein the salt is the 2,4,6-trimethylbenzenesulfonic acid salt.

Join the waitlist — get patent alerts

Track US2009062532A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.